SouthState Corporation Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K, dated January 2, 2025, announces the completion of the merger between Independent Bank Group, Inc. ("IBTX") and SouthState Corporation ("SouthState"). The merger closed on January 1, 2025, with SouthState continuing as the surviving corporation. IBTX is no longer a separate legal entity, and its common stock has been delisted from the NASDAQ.
Key Financial Metrics and Transaction Details
- Consideration: Approximately 24.9 million shares of SouthState Common Stock were issued to IBTX shareholders.
- Exchange Ratio: 0.60 shares of SouthState Common Stock for each share of IBTX Common Stock.
- Debt Assumption: SouthState assumed IBTX's outstanding indebtedness, including:
- $57.324 million in Trust Preferred Securities.
- $130 million in 4.00% fixed-to-floating rate subordinated notes due 2030.
- $175.0 million in 8.375% fixed-to-floating rate subordinated debentures due 2034.
- Financial Results: This filing does not contain specific revenue, profit, cash flow, or margin data for the reporting period. SouthState announced it will release fourth quarter 2024 earnings results on January 23, 2025.
Material Changes
The primary material change is the consolidation of IBTX into SouthState. This transaction resulted in the issuance of new equity, the assumption of approximately $362.3 million in IBTX debt obligations, and the delisting of IBTX stock. Additionally, three former IBTX directors (David R. Brooks, G. Stacy Smith, and Janet Froetscher) were appointed to the SouthState Board of Directors effective at the closing.
Outlook, Risks, and Unusual Items
Management Commentary and Outlook: Management has scheduled a conference call for January 24, 2025, to discuss fourth quarter 2024 results. No specific forward-looking guidance or risk factors regarding the merger's financial impact are detailed in this specific filing beyond the assumption of debt and equity dilution.
Unusual Items: The filing notes that IBTX's reporting obligations under Sections 13 and 15(d) of the Exchange Act are being suspended as the entity no longer exists separately.
Investor Verification Checklist
- Verify the exact number of shares issued and the final exchange ratio implementation in the definitive Merger Agreement (Exhibit 2.1).
- Review the upcoming Q4 2024 earnings release (scheduled for January 23, 2025) for pro forma financial impacts of the merger.
- Confirm the terms of the assumed debt instruments (2030 Notes, 2034 Notes, and Trust Preferred Securities) via the supplemental indentures filed as Exhibits 4.1 through 4.7.
- Monitor the transition of IBTX executive officers and directors as outlined in the Transition Agreements referenced in the Joint Proxy Statement/Prospectus.